Role of ecto-kinase in phorbol ester-enhanced growth hormone-binding protein release from human IM-9 cells

Molecular and Cellular Endocrinology

Volumn 152, Issue 1-2, 1999, Pages 65-72

  Saito, Y ^a   Takagi, K ^a   Teshima, R ^a   Ikebuchi, H ^a   Yamazaki, T ^a   Sawada, J ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Ecto kinase; Human growth hormone binding protein; Phorbol ester

Indexed keywords

BAFILOMYCIN A1; BISINDOLYLMALEIMIDE; CELL SURFACE RECEPTOR; CHLOROQUINE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; K 252A; K 252B; PHORBOL DIACETATE; PHORBOL ESTER; TRYPSIN;

ARTICLE; CELL STIMULATION; CELL SURFACE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INHIBITION KINETICS; LYMPHOMA CELL LINE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION;

CARBAZOLES; CARCINOGENS; CARRIER PROTEINS; CELL LINE; ENZYME INHIBITORS; HUMANS; PROTEIN KINASE C; PROTEIN KINASES; TETRADECANOYLPHORBOL ACETATE;

EID: 0033603469     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00055-6     Document Type: Article

References (45)

1. Aicher B., Lerch M.M., Muller T., Schilling J., Ullrich A. Cellular redistribution of protein tyrosine phosphatases LAR and PTPσ by inducible proteolytic processing. J. Cell Biol. 138:1997;681-696.
2. Alele J., Jiang J., Goldsmith J.F. et al. Blockade of growth hormone receptor shedding by a metalloprotease inhibitor. Endocrinology. 139:1998;1927-1935.
3. Amano F., Kitagawa T., Akamatsu Y. Protein kinase activity on the cell surface of a macrophage-like cell line, J774.1 cells. Biochem. Biophys. Acta. 803:1984;163-173.
4. Amit T., Hacham H., Daily O., Herz P., Barkey R.J., Hochberg Z. The Hep G2 cell line in the study of growth hormone receptor/binding protein. Mol. Cell. Endocrinol. 101:1994;29-36.
5. Amit T., Bick T., Youdim M.B.H., Hochberg Z. In search of the cellular site of growth hormone (GH)-binding protein cleavage from the rabbit GH receptor. Endocrinology. 137:1996;3986-3991.
6. Apasov S.G, Smith P.T., Jelonek M.T., Margulies D.H., Sitkovsky M.V. Phosphorylation of extracellular domains of T-lymphocyte surface receptor. J. Biol. Chem. 271:1996;25677-25683.
7. Bazil V. Physiological enzymatic cleavage of leukocyte membrane molecules. Immunol. Today. 16:1995;135-140.
8. Baumann G, Stolar M.W., Amburn K., Barsano C.P., DeVries B.C. A specific growth hormone-binding protein in human plasma: initial characterization. J. Clin. Endocrinol. Metab. 62Table:1986;134-141.
9. Baumann G, Shaw M.A., Amburn K. Circulating growth hormone binding proteins. J. Endocrinol. Invest. 17:1994;67-81.
10. Baumbach W.R., Horner D.L., Logan J.S. The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes Dev. 3:1989;1199-1205.
11. Bick T., Amit T., Mansur M., Bar-Am O., Youdim M.B.H., Hochberg Z. Regulation of cellular rabbit growth hormone (GH) receptor and GH-binding protein generation in vitro. Endocrinology. 137:1996;3977-3985.
12. Brakebusch C., Nophar Y., Kemper O., Engelmann H., Wallach D. Cytoplasmic truncation of the pS5 tumor necrosis factor (TNF) receptor abolishes signaling, but not induced shedding of the receptor. EMBO J. 11:1992;943-950.
13. Chen W., Wieraszko A., Hogan M.V., Yang H-A., Kornecki E., Ehrlich Y.H. Surface protein phosphorylation by ecto-protein kinase is required for the maintenance of hippocampal long-term potentiation. Proc. Natl. Acad. Sci. USA. 93:1996;8688-8693.
14. Crowe P.D., VanArsdale T.L., Goodwin R.G, Ware C.F. Specific induction of 80-kDa tumor necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation. J. Immunol. 151:1993;6882-6890.
15. Dastot F., Sobrier M.-L., Duquesnoy P., Duriez B., Goossens M., Amselem S. Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH binding protein. Proc. Natl. Acad. Sci. USA. 93:1996;10723-10728.
16. Harrison S.M., Barnard R., Ho K.K.Y., Rajkovic I., Waters M.J. Control of growth hormone (GH) binding protein release from human hepatoma cells expressing full-length GH receptor. Endocrinology. 136:1995;651-659.
17. Herington A.C., Ymer S.I., Stevenson J.L. Identification and characterization of specific binding proteins for growth hormone in normal human sera. J. Clin. Invest. 77:1986;1817-1823.
18. Hogan M.V., Pawlowska Z., Yang H.-A., Kornecki E., Ehrlich Y.H. Surface phosphorylation by ecto-protein kinase C in brain neurones: a target for Alzheimer's, β-amyloid peptides. J. Neurochem. 65:1995;2022-2030.
19. House C., Kemp B.E. Protein kinase C pseudosubstrate prototope: structure-function relationships. Cell. Signal. 2:1990;187-190.
20. Kase H., Iwahashi K., Nakanishi S. et al. K252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinase. Biochem. Biophys. Res. Commun. 142:1987;436-440.
21. Kitakaze M., Funaya H., Minamino T. et al. Role of protein kinase C-α in activation of ecto-5′-nucleotidase in the preconditioned canine myocardium. Biochem. Biophys. Res. Commun. 239:1997;171-175.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
23. Leung D.W., Spencer S.A., Cachianes G et al. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature. 330:1987;537-543.
24. Merlo D., Anelli R., Calissano P., Ciotti M., Velonte C. Characterization of an ecto-phosphorylated protein of cultured cerebellar granule neurones. J. Neurosci. Res. 47:1997;500-508.
25. Mullberg J., Oberthur W., Lottspeich F. et al. The soluble human IL-6 receptor: mutational characterization of the proteolytic cleavage site. J. Immunol. 152:1994;4958-4968.
26. Muramoto K., Taniguchi H., Kawahara M., Kobayashi K., Nonomura Y., Kuroda Y. A substrate of ecto-protein kinase is microtuble-associated protein 1B in cortical cell cultures undergoing synaptogenesis. Biochem. Biophys. Res. Commun. 205:1994;1467-1473.
27. Nakanishi S., Yamada K, Iwahashi K., Kuroda K, Kase H. KT5926, a potent and selective inhibitor of myosin light chain kinase. Mol. Pharmcol. 37:1990;482-488.
28. Nagashima K., Nakanishi S., Matsuda Y. Inhibition of nerve growth factor induced neurite outgrowth of PC12 cells by a protein kinase inhibitior which does not permeate the cell membrane. FEBS Lett. 293:1991;119-123.
29. 1 treatment retards transferrin receptor recycling more than bulk membrane recycling. J. Biol. Chem. 272:1997;13929-13936.
30. Ross A.H., McKinnon C.A., Daou M.C., Ratliff K, Wolf D.E. Differential biological effects of K252 kinase inhibitors are related to membrane solubility but not permeability. J. Neurochem. 65:1995;2748-2756.
31. Ross R.J.M., Esposito N., Shen X.Y. et al. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates a large amount of binding protein. Mol. Endocrinol. 11:1997;265-273.
32. Sadeghi H., Wang B.S., Lumanglas A.L., Logan J.S., Baumbach W.R. Identification of the origin of the growth hormone-binding protein in rat serum. Mol. Endocrinol. 4:1990;1799-1805.
33. Saito Y., Yamazaki T., Suzuki K. et al. Preparation of monoclonal antibodies for immunoblotting human growth hormone receptor and growth hormone-binding protein. Biol. Pharm. Bull. (Tokyo). 17:1994;983-986.
34. Saito Y., Teshima R., Yamazaki T., Ikebuchi H., Sawada J. Ligand-induced internalization and phosphorylation-dependent degradation of growth hormone receptor in human IM-9 cells. Mol. Cell. Endocrinol. 106:1994;67-74.
35. Saito Y., Ikebuchi H., Yamazaki T., Sawada J. Release of a soluble form of growth hormone receptors (growth hormone-binding proteins) from human IM-9 cells by proteolytic cleavage. J. Biochem. 118:1995;521-525.
36. Saito, Y., Teshima, R., Takagi, K., Ikebuchi, H., Yamazaki, T., Sawada, J., 1998. Activation of protein kinase Cα enhances human growth hormone-binding protein release. Mol. Cell. Endocrinol. in press.
37. Smith W.C., Kuniyoshi J., Talamantes F. Mouse serum growth hormone (GH) binding protein has GH receptor extracellular and substituted transmembrane domains. Mol. Endocrinol. 3:1989;984-990.
38. Smith M.K., Colbran R.J., Soderling T.R. Specificities of autoinhibitory domain peptides for four protein kinases. J. Biol. Chem. 265:1990;1837-1840.
39. Sotiropoulos A., Goujon L., Simonin G, Kelly P.A., Postel-Vinay M.-C., Finidori J. Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor. Endocrinology. 132:1993;1863-1865.
40. Suzuki K., Suzuki S., Saito Y., Ikebuchi H., Terao T. Human growth hormone-stimulated growth of human cultured lymphocytes (IM-9) and its inhibition by phorbol diesters through down-regulation of the hormone receptors. Possible involvement of phosphorylation of a 55 000 molecular weight protein associated with the receptor in the down-regulation. J. Biol. Chem. 265:1990;11320-11327.
41. 2+ signals of RBL-2H3 cells and human basophils. J. Immunol. 159:1997;964-969.
42. Trivedi B., Daughaday W.H. Release of growth hormone binding protein from IM-9 lymphocytes by endopeptidase is dependent on sulfydryl group inactivation. Endocrinology. 123:1988;2201-2206.
43. Tsuji S., Yamashita T., Matsuda Y., Nagai Y. A novel glycosignaling system: GQlb-dependent neurite genesis of human neuroblastoma cell line, GOTO, is closely associated with GQlb-dependent ecto-type protein phosphorylation. Neurochem. Int. 21:1992;549-554.
44. Urbanek M., MacLeod J.N., Cooke N.E., Liebhaber S.A. Expression of a human growth hormone (hGH) receptor isoform is predicted by tissue-specific alternative splicing of exon 3 of the hGH receptor gene transcript. Mol. Endocrinol. 6:1992;279-287.
45. Ymer S.I., Herington A.C. Evidence for the specific binding of growth hormone to a receptor-like protein in rabbit serum. Mol. Cell. Endocrinol. 41:1985;153-161.